LabVantage Solutions Launches Version 8.8 of Flagship LIMS Platform

Enhancements designed to provide improvements in accuracy, speed, usability and security.

By: Kristin Brooks

Managing Editor, Contract Pharma

LabVantage Solutions, Inc., a provider of laboratory informatics solutions and services, including purpose-built LIMS solutions, has launched version 8.8 of its LabVantage LIMS platform. LabVantage 8.8 includes multiple enhancements designed to improve the accuracy, speed, usability, and security of LabVantage’s LIMS components, including its integrated electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics.

LabVantage 8.8 is available to support the more than 1500 global customer sites in the life sciences, pharmaceutical, medical device, biobank, food and beverage, consumer packaged goods, oil & gas, genetics/diagnostics, forensic, and healthcare industries that rely on the LabVantage platform.
 
Key improvements and enhanced capabilities include:

Intelligent Approvals uses rules-based AI to streamline and speed data reviews. Version 8.8 enables manual approvals by exception only, allowing automatic approvals when there are no exceptions. 

Automatic Redo Calculations automatically triggers re-calculation when a reference is modified, allowing users to focus on the task at hand, while improving accuracy and data quality.

Enhanced Cybersecurity against OWASP Top 10 threats includes 3rd party certification of testing. A widely accepted standard for web application developers, OWASP Top 10 represents a broad consensus about critical cybersecurity risks. 

Accessibility for improved compliance with the Web Content Accessibility Guidelines (WCAG) international standard, Section 508, intended to facilitate access to the platform for users who have visual or other accessibility problems. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters